<code id='CCC4CEE09E'></code><style id='CCC4CEE09E'></style>
    • <acronym id='CCC4CEE09E'></acronym>
      <center id='CCC4CEE09E'><center id='CCC4CEE09E'><tfoot id='CCC4CEE09E'></tfoot></center><abbr id='CCC4CEE09E'><dir id='CCC4CEE09E'><tfoot id='CCC4CEE09E'></tfoot><noframes id='CCC4CEE09E'>

    • <optgroup id='CCC4CEE09E'><strike id='CCC4CEE09E'><sup id='CCC4CEE09E'></sup></strike><code id='CCC4CEE09E'></code></optgroup>
        1. <b id='CCC4CEE09E'><label id='CCC4CEE09E'><select id='CCC4CEE09E'><dt id='CCC4CEE09E'><span id='CCC4CEE09E'></span></dt></select></label></b><u id='CCC4CEE09E'></u>
          <i id='CCC4CEE09E'><strike id='CCC4CEE09E'><tt id='CCC4CEE09E'><pre id='CCC4CEE09E'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:8675
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Hey, doctors: Don't be no
          Hey, doctors: Don't be no

          StephenMaturen/GettyImagesPhysiciansdomanythingswell.Onethingtheyaren’tgoodatisshowinguptovote.Thatb

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

          AdobeDiagnosticerrors—thatis,overlookingadisease,ordiagnosingiterroneouslyorlate—areaknownoccurrence